BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 17545591)

  • 1. X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.
    Vincent-Salomon A; Ganem-Elbaz C; Manié E; Raynal V; Sastre-Garau X; Stoppa-Lyonnet D; Stern MH; Heard E
    Cancer Res; 2007 Jun; 67(11):5134-40. PubMed ID: 17545591
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.
    Sirchia SM; Ramoscelli L; Grati FR; Barbera F; Coradini D; Rossella F; Porta G; Lesma E; Ruggeri A; Radice P; Simoni G; Miozzo M
    Cancer Res; 2005 Mar; 65(6):2139-46. PubMed ID: 15781624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRCA1 does not paint the inactive X to localize XIST RNA but may contribute to broad changes in cancer that impact XIST and Xi heterochromatin.
    Pageau GJ; Hall LL; Lawrence JB
    J Cell Biochem; 2007 Mar; 100(4):835-50. PubMed ID: 17146760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of BRCA1 with the inactive X chromosome and XIST RNA.
    Ganesan S; Silver DP; Drapkin R; Greenberg R; Feunteun J; Livingston DM
    Philos Trans R Soc Lond B Biol Sci; 2004 Jan; 359(1441):123-8. PubMed ID: 15065664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X chromosomal abnormalities in basal-like human breast cancer.
    Richardson AL; Wang ZC; De Nicolo A; Lu X; Brown M; Miron A; Liao X; Iglehart JD; Livingston DM; Ganesan S
    Cancer Cell; 2006 Feb; 9(2):121-32. PubMed ID: 16473279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MYB oncogene amplification in hereditary BRCA1 breast cancer.
    Kauraniemi P; Hedenfalk I; Persson K; Duggan DJ; Tanner M; Johannsson O; Olsson H; Trent JM; Isola J; Borg A
    Cancer Res; 2000 Oct; 60(19):5323-8. PubMed ID: 11034064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors.
    Kawakami T; Okamoto K; Sugihara H; Hattori T; Reeve AE; Ogawa O; Okada Y
    J Urol; 2003 Apr; 169(4):1546-52. PubMed ID: 12629412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammary tumors in mice conditionally mutant for Brca1 exhibit gross genomic instability and centrosome amplification yet display a recurring distribution of genomic imbalances that is similar to human breast cancer.
    Weaver Z; Montagna C; Xu X; Howard T; Gadina M; Brodie SG; Deng CX; Ried T
    Oncogene; 2002 Aug; 21(33):5097-107. PubMed ID: 12140760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.
    Ganesan S; Richardson AL; Wang ZC; Iglehart JD; Miron A; Feunteun J; Silver D; Livingston DM
    Cold Spring Harb Symp Quant Biol; 2005; 70():93-7. PubMed ID: 16869742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
    Lose F; Duffy DL; Kay GF; Kedda MA; Spurdle AB; ;
    J Natl Cancer Inst; 2008 Nov; 100(21):1519-29. PubMed ID: 18957670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletions on chromosome 4 in sporadic and BRCA mutated tumors and association with pathological variables.
    Johannsdottir HK; Johannesdottir G; Agnarsson BA; Eerola H; Arason A; Johannsson OT; Heikkilä P; Egilsson V; Olsson H; Borg A; Nevanlinna H; Barkardottir RB
    Anticancer Res; 2004; 24(5A):2681-7. PubMed ID: 15521105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further evidence for BRCA1 communication with the inactive X chromosome.
    Silver DP; Dimitrov SD; Feunteun J; Gelman R; Drapkin R; Lu SD; Shestakova E; Velmurugan S; Denunzio N; Dragomir S; Mar J; Liu X; Rottenberg S; Jonkers J; Ganesan S; Livingston DM
    Cell; 2007 Mar; 128(5):991-1002. PubMed ID: 17350581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization.
    Jönsson G; Naylor TL; Vallon-Christersson J; Staaf J; Huang J; Ward MR; Greshock JD; Luts L; Olsson H; Rahman N; Stratton M; Ringnér M; Borg A; Weber BL
    Cancer Res; 2005 Sep; 65(17):7612-21. PubMed ID: 16140926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations.
    van Beers EH; van Welsem T; Wessels LF; Li Y; Oldenburg RA; Devilee P; Cornelisse CJ; Verhoef S; Hogervorst FB; van't Veer LJ; Nederlof PM
    Cancer Res; 2005 Feb; 65(3):822-7. PubMed ID: 15705879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic heterogeneity by comparative genomic hybridization in BRCAx breast cancers.
    Mangia A; Chiarappa P; Tommasi S; Chiriatti A; Petroni S; Schittulli F; Paradiso A
    Cancer Genet Cytogenet; 2008 Apr; 182(2):75-83. PubMed ID: 18406868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.
    Focken T; Steinemann D; Skawran B; Hofmann W; Ahrens P; Arnold N; Kroll P; Kreipe H; Schlegelberger B; Gadzicki D
    Cytogenet Genome Res; 2011; 135(2):84-92. PubMed ID: 22024613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification.
    Orsetti B; Courjal F; Cuny M; Rodriguez C; Theillet C
    Oncogene; 1999 Nov; 18(46):6262-70. PubMed ID: 10597224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A paradox and three egnimas about the role of BRCA1 in breast and ovarian cancers].
    Feunteun J
    J Soc Biol; 2004; 198(2):123-6. PubMed ID: 15368961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The retinoblastoma gene undergoes rearrangements in BRCA1-deficient basal-like breast cancer.
    Jönsson G; Staaf J; Vallon-Christersson J; Ringnér M; Gruvberger-Saal SK; Saal LH; Holm K; Hegardt C; Arason A; Fagerholm R; Persson C; Grabau D; Johnsson E; Lövgren K; Magnusson L; Heikkilä P; Agnarsson BA; Johannsson OT; Malmström P; Fernö M; Olsson H; Loman N; Nevanlinna H; Barkardottir RB; Borg Å
    Cancer Res; 2012 Aug; 72(16):4028-36. PubMed ID: 22706203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCoR-L1 variation and breast cancer.
    Lose F; Arnold J; Young DB; Brown CJ; Mann GJ; Pupo GM; ; Khanna KK; Chenevix-Trench G; Spurdle AB
    Breast Cancer Res; 2007; 9(4):R54. PubMed ID: 17697391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.